The global blood collection market size is expected to reach USD 19.86 billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period. Moreover, the global burden of chronic diseases is rising rapidly. Cardiovascular disease (CVD) accounts for nearly half of all chronic disease deaths. According to the American Heart Association, the incidence of CVD in the U.S. is estimated to rise from 36.9 % (2010) to 38.7 % (2020) and 40.5% by 2030.The COVID-19 pandemic had a significant impact on the market, encompassing both direct and indirect effects. Initially, the consumption of blood collection devices for conventional diseases was reduced due to the disruption caused by the pandemic and the strain on healthcare resources.
However, as it became apparent that other diseases could be life-threatening risks for individuals infected with COVID-19, there was an increased emphasis on routine checks for blood-related diseases. This led to a temporary surge in sales in the market, which eventually led the market gradually return to its projected growth rate in 2022.The growing rate of novel product launches and investments is anticipated to fuel market growth during the forecast period. For instance, in May 2022, Terumo Blood and Cell Technologies announced the opening of its new production plant in Colorado. The plant will cater to customers in the source plasma collections by providing single-use collection kits for the newly FDA-approved Rika Plasma Donation System. This will ensure a reliable supply of collection sets specifically designed for the Rika system.
Request a free sample copy or view report summary: Blood Collection Market Report
The venous blood collection segment held the highestrevenue share in 2022 owing to an increase in demand for detection and diagnosis medical equipment
The diagnostics application segment held the largest revenue share in 2022 due to the high geriatric population and the prevalence of infectious & non-communicable diseases
In 2022, the manual collectionmethod segment accounted for the largest market share in terms of revenue owing to the wide usage of this method in hospitals, individual clinical laboratories, and pathology laboratories
However, growing demand for safe & secure procedures and the adoption of enhanced blood collection products are driving the growth of the automated collection method segment
In 2022, the hospitals segment accounted for the largest share due to an upsurge in the incidence of trauma & accidental cases along with a highvolume of surgical procedures
North America held the largest revenue share in 2022, which can be attributed to the presence of a highly developed healthcare infrastructure and advanced blood collection products
In May 2022 QIAxcel Connect, a high-speed, high-sensitivity, high-resolution, nucleic acid analysis capillary electrophoresis device, was introduced by QIAGEN. QIAxcel Connect provides greater ease owing to its simplicity of use, better flexibility, and low operating costs. It has high analytical power and applies to a wide range of applications
Grand View Research has segmented the global blood collection market on the basis of collection site, method, application, end-use, and region:
Blood Collection Site Outlook (Revenue, USD Million, 2018 - 2030)
Venous
Needles and Syringes
Double-Ended Needles
Winged Blood Collection Sets
Standard Hypodermic Needles
Other Blood Collection Needles
Blood Collection Tubes
Serum-separating
EDTA
Heparin
Plasma-separating
Blood Bags
Others
Capillary
Lancets
Micro-Container Tubes
Micro-Hematocrit Tubes
Warming Devices
Others
Blood Collection Application Outlook (Revenue, USD Million, 2018 - 2030)
Diagnostics
Treatment
Blood Collection Method Outlook (Revenue, USD Million, 2018 - 2030)
Manual Blood Collection
Automated Blood Collection
Blood Collection End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostics Centers
Blood Banks
Emergency Departments
Others
Blood Collection Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Russia
Asia Pacific
China
India
Japan
Thailand
Australia
South Korea
Singapore
Latin America
Brazil
Mexico
Argentina
MEA
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Blood Collection Market
Abbott Laboratories
NIPRO Medical Corp.
BD
Terumo Corp.
Medtronic Plc
Qiagen
FL Medical s.r.l.
Greiner Holding AG
Haemonetics Corp.
"The quality of research they have done for us has been excellent..."